Bottom line: clinical trial successes for IPIX's d
Post# of 72430
![Avatar](/images/ProfileImages/424989898_3046_Avatar jpeg2.jpg)
And we have 3 completely different drugs, for multiple applications, with successful clinical trials. In my opinion the stock price should be at a minimum of 5 right now, and that is really not pricing in the magnitude of the pipeline and the clinical trial successes.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)